DOCSLIB.ORG

Screening for Atrial Fibrillation with Electrocardiography: an Evidence Review for the U.S

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Screening for Atrial Fibrillation with Electrocardiography: an Evidence Review for the U.S Evidence Synthesis Number 164 Screening for Atrial Fibrillation With Electrocardiography: An Evidence Review for the U.S. Preventive Services Task Force Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No. HHSA-290-2015-00011-I, Task Order No. 7 Prepared by: RTI International–University of North Carolina Evidence-based Practice Center Research Triangle Park, NC 27709 Investigators: Daniel E. Jonas, MD, MPH Leila C. Kahwati, MD, MPH Jonathan D.Y. Yun, MD Jennifer Cook Middleton, PhD Manny Coker-Schwimmer, MPH Gary N. Asher, MD, MPH AHRQ Publication No. 17-05236-EF-1 August 2018 This report is based on research conducted by the RTI International–University of North Carolina Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (Contract No. HHSA-290-2015-00011-I, Task Order No. 7). The findings and conclusions in this document are those of the authors, who are responsible for its contents, and do not necessarily represent the views of AHRQ. Therefore, no statement in this report should be construed as an official position of AHRQ or of the U.S. Department of Health and Human Services. The information in this report is intended to help health care decisionmakers—patients and clinicians, health system leaders, and policymakers, among others—make well-informed decisions and thereby improve the quality of health care services. This report is not intended to be a substitute for the application of clinical judgment. Anyone who makes decisions concerning the provision of clinical care should consider this report in the same way as any medical reference and in conjunction with all other pertinent information (i.e., in the context of available resources and circumstances presented by individual patients). This report may be used, in whole or in part, as the basis for development of clinical practice guidelines and other quality enhancement tools, or as a basis for reimbursement and coverage policies. AHRQ or U.S. Department of Health and Human Services endorsement of such derivative products may not be stated or implied. None of the investigators has any affiliations or financial involvement that conflicts with the material presented in this report. Acknowledgments The authors gratefully acknowledge the following individuals for their contributions to this project: Elisabeth Kato, MD, MRP, and Howard Tracer, MD, AHRQ Medical Officers; Tracy Wolff, MD, MPH, AHRQ Associate Scientific Director; current and former members of the U.S. Preventive Services Task Force who contributed to topic deliberations; expert reviewers David A Fitzmaurice, MBChB, MRCGP, MD, Richard Hobbs, MA, Stephen Morgan, MA, MB, BChir, MSc, MRCG, and Larisa G. Tereshchenko, MD, PhD; Federal partner reviewers at the Centers for Disease Control and Prevention; and RTI International–University of North Carolina EPC staff Carol Woodell, BSPH; Josh Green, BA; Christiane Voisin, MSLS; Claire Korzen, BA; Sharon Barrell, and Loraine Monroe. Suggested Citation Jonas DE, Leila C. Kahwati LC, Yun JD, Middleton JC, Coker-Schwimmer M, Asher GN. Screening for Atrial Fibrillation With Electrocardiography: An Evidence Review for the U.S. Preventive Services Task Force. Evidence Synthesis No. 164. AHRQ Publication No. 17-05236- EF-1. Rockville, MD: Agency for Healthcare Research and Quality; 2018. Screening for Atrial Fibrillation With ECG ii RTI–UNC EPC Structured Abstract Purpose: To systematically review the evidence on screening for and stroke prevention treatment of nonvalvular atrial fibrillation (AF) in adults age 65 years or older for populations and settings relevant to primary care in the United States. Data Sources: PubMed/MEDLINE, the Cochrane Library, and trial registries through May 24, 2017; reference lists of retrieved articles; outside experts; and reviewers, with surveillance of the literature through June 6, 2018. Study Selection: Two investigators selected English-language studies using a priori criteria. Eligible studies included controlled trials of screening for or treatment of AF, controlled prospective cohort studies evaluating detection rates of previously unknown AF or harms of screening or treatment, and systematic reviews of trials evaluating benefits or harms of treatment. Eligible screening tests included electrocardiogram (ECG) screening (e.g., 12-lead ECG, intermittent handheld ECG) or screening with both pulse palpation and ECG for all participants. Eligible treatment studies compared warfarin, aspirin, or novel oral anticoagulants (NOACs: apixaban, dabigatran, edoxaban, or rivaroxaban) with placebo or no treatment. Studies focused on persons younger than age 65 or those with a history of stroke, transient ischemic attack, known heart disease, or heart failure were excluded. Data Extraction: One investigator extracted data and a second checked accuracy. Two reviewers independently rated quality for all included studies using predefined criteria. Data Synthesis: Seventeen unique studies (described in 22 publications) were included. No eligible studies evaluated screening compared with no screening and focused on health outcomes. Systematic screening with ECG identified more new cases of AF than no screening (absolute increase with 12-lead ECG, 0.6% [0.1% to 0.98%] over 12 months; absolute increase with twice-weekly single-lead ECG, 2.8% [95% CI, 0.9% to 4.7%] over 12 months), but a systematic approach using ECG did not detect more cases than an opportunistic approach focused on pulse palpation. Warfarin treatment for an average of 1.5 years was associated with a reduced risk of ischemic stroke (pooled relative risk [RR], 0.32 [0.20 to 0.51]) and all-cause mortality (pooled RR, 0.68 [0.50 to 0.93]), and an increased risk of major bleeding (pooled RR, 1.8 [0.85 to 3.7]) compared with controls (5 trials; 2,415 participants). Treatment trial participants were not screen-detected; mean age was 67 to 74 years; very few had a history of TIA or stroke (3%-8%); most had long-standing persistent AF; and baseline stroke risk scores were not reported. For a population of 1,000 adults age 65 or older with an annual stroke risk of 4 percent, this translates to an absolute reduction of 28 ischemic strokes and 16 deaths per year and an absolute increase of five major bleeding events per year. Aspirin treatment for an average of 1.5 years was associated with a reduced risk of ischemic stroke (pooled RR, 0.76 [0.52 to 1.1]) and all-cause mortality (pooled RR, 0.84 [0.62 to 1.14]) compared with controls, but the differences were not statistically significant (3 trials; 2,663 participants). A network meta- analysis found that all treatments reduced the risk of a composite outcome (any stroke and systemic embolism) and all-cause mortality. For NOACs, it found statistically significant associations with reduction in the composite outcome compared with placebo/control (adjusted odds ratios [ORs] from 0.32 to 0.44), and an increased risk of bleeding compared with Screening for Atrial Fibrillation With ECG iii RTI–UNC EPC placebo/control (adjusted ORs from 1.38 to 2.21), but confidence intervals for the risk of bleeding were wide and differences between groups were not statistically significant. Limitations: This review is limited in the ability to describe the direct evidence on the effectiveness or harms of screening for AF because we identified no eligible studies that aimed to address the overarching question. For potential harms of screening (e.g., overdiagnosis from misinterpretation of ECGs, subsequent interventions leading to harms), no eligible studies provided information that allowed comparison between screening and no-screening. No eligible stroke prevention treatment studies focused on asymptomatic, screen-detected participants. The included trials that evaluated warfarin benefits and harms had an average of 1.5 years of followup and were stopped early. Estimates for benefits and harms of lifelong anticoagulation and for screen-detected persons were not available. Conclusions: There is uncertainty about the benefits and harms of screening for AF with ECG. Although screening with ECG can detect previously unknown cases of AF, it has not been shown to detect more cases than opportunistic screening that is focused on pulse palpation. Most older adults with previously unknown AF have a stroke risk above the threshold for anticoagulation. Multiple treatments for AF reduce the risk of stroke and all-cause mortality, and increase the risk of bleeding, but trials have not assessed whether treatment of screen-detected asymptomatic older adults results in better health outcomes than treatment after detection by usual care or after symptoms develop. Screening for Atrial Fibrillation With ECG iv RTI–UNC EPC Table of Contents Chapter 1. Introduction......................................................................................................... 1 Scope and Purpose ............................................................................................................... 1 Condition Definition ............................................................................................................ 1 Etiology and Natural History................................................................................................ 1 Risk Factors......................................................................................................................... 2 Prevalence and Burden........................................................................................................
Load more

Recommended publications
  • Left Ventricular Wall Findings in Non-Electrocardiography-Gated CE-CT After ECPR Might Be Useful for Diagnosis and Prognostic Prediction
    Sugiyama et al. Critical Care (2019) 23:357 https://doi.org/10.1186/s13054-019-2624-1 RESEARCH Open Access Left ventricular wall findings in non- electrocardiography-gated contrast- enhanced computed tomography after extracorporeal cardiopulmonary resuscitation Kazuhiro Sugiyama1* , Masamichi Takahashi2, Kazuki Miyazaki1, Takuto Ishida1, Mioko Kobayashi1 and Yuichi Hamabe1 Abstract Background: Few studies have reported left ventricular wall findings in contrast-enhanced computed tomography (CE-CT) after extracorporeal cardiopulmonary resuscitation (ECPR). This study examined left ventricular wall CE-CT findings after ECPR and evaluated the association between these findings and the results of coronary angiography and prognosis. Methods: We evaluated out-of-hospital cardiac arrest patients who were treated with ECPR and subsequently underwent both non-electrocardiography-gated CE-CT and coronary angiography at our center between January 2011 and April 2018. Left ventricular wall CE-CT findings were classified as follows: (1) homogeneously enhanced (HE; the left ventricular wall was homogeneously enhanced), (2) segmental defect (SD; the left ventricular wall was not segmentally enhanced according to the coronary artery territory), (3) total defect (TD; the entire left ventricular wall was not enhanced), and (4) others. Successful weaning from extracorporeal membrane oxygenation, survival to hospital discharge, and predictive ability of significant stenosis on coronary angiography were compared among patients with HE, SD, and TD patterns. Results: A total of 74 patients (median age, 59 years) were eligible, 50 (68%) of whom had initial shockable rhythm. Twenty-three (31%) patients survived to hospital discharge. HE, SD, TD, and other patterns were observed in 19, 33, 11, and 11 patients, respectively. The rates of successful weaning from extracorporeal membrane oxygenation (84% vs.
    [Show full text]
  • Sparse-Input Detection Algorithm with Applications in Electrocardiography and Ballistocardiography
    Sparse-input Detection Algorithm with Applications in Electrocardiography and Ballistocardiography ;1 ;1 2 1 1 F. Wadehn∗ , L. Bruderer∗ , D. Waltisberg , T. Keresztfalvi and H.-A. Loeliger 1 Signal and Information Processing Laboratory, ETH Zurich, Gloriastrasse 35, Zurich, Switzerland 2 Institut fuer Elektronik, ETH Zurich, Gloriastrasse 35, Zurich, Switzerland Keywords: Ballistocardiography, Heart Rate Estimation, Hypothesis Test, Factor Graphs, System identification, State- space Models, Maximum likelihood, Maximum a posteriori. Abstract: Sparse-input learning, especially of inputs with some form of periodicity, is of major importance in bio- signal processing, including electrocardiography and ballistocardiography. Ballistocardiography (BCG), the measurement of forces on the body, exerted by heart contraction and subsequent blood ejection, allows non- invasive and non-obstructive monitoring of several key biomarkers such as the respiration rate, the heart rate and the cardiac output. In the following we present an efficient online multi-channel algorithm for estimating single heart beat positions and their approximate strength using a statistical hypothesis test. The algorithm was validated with 10 minutes long ballistocardiographic recordings of 12 healthy subjects, comparing it to synchronized surface ECG measurements. The achieved mean error rate for the heart beat detection excluding movement artifacts was 4:7%. 1 INTRODUCTION Early signal-processing methods for BCG signals (Watanabe et al., 2005; Mack et al., 2009) concerned Cardiovascular diseases are among the leading causes estimation of heart rates averaged over a few sec- of death and severe health impairments both in high- onds using frequency-based methods. These meth- income countries with an aging population, as well ods do not provide beat-to-beat resolution or infor- as in developing countries, which are increasingly mation on irregular arrhythmias.
    [Show full text]
  • 2Nd Quarter 2001 Medicare Part a Bulletin
    In This Issue... From the Intermediary Medical Director Medical Review Progressive Corrective Action ......................................................................... 3 General Information Medical Review Process Revision to Medical Record Requests ................................................ 5 General Coverage New CLIA Waived Tests ............................................................................................................. 8 Outpatient Hospital Services Correction to the Outpatient Services Fee Schedule ................................................................. 9 Skilled Nursing Facility Services Fee Schedule and Consolidated Billing for Skilled Nursing Facility (SNF) Services ............. 12 Fraud and Abuse Justice Recovers Record $1.5 Billion in Fraud Payments - Highest Ever for One Year Period ........................................................................................... 20 Bulletin Medical Policies Use of the American Medical Association’s (AMA’s) Current Procedural Terminology (CPT) Codes on Contractors’ Web Sites ................................................................................. 21 Outpatient Prospective Payment System January 2001 Update: Coding Information for Hospital Outpatient Prospective Payment System (OPPS) ......................................................................................................................... 93 he Medicare A Bulletin Providers Will Be Asked to Register Tshould be shared with all to Receive Medicare Bulletins and health care
    [Show full text]
  • Electrocardiography: a Technologist's Guide to Interpretation
    CONTINUING EDUCATION Electrocardiography: A Technologist’s Guide to Interpretation Colin Tso, MBBS, PhD, FRACP, FCSANZ1,2, Geoffrey M. Currie, BPharm, MMedRadSc(NucMed), MAppMngt(Hlth), MBA, PhD, CNMT1,3, David Gilmore, ABD, CNMT, RT(R)(N)3,4, and Hosen Kiat, MBBS, FRACP, FACP, FACC, FCCP, FCSANZ, FASNC, DDU1,2,3,5 1Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia; 2Cardiac Health Institute, Sydney, New South Wales, Australia; 3Faculty of Science, Charles Sturt University, Wagga Wagga, New South Wales, Australia; 4Faculty of Medical Imaging, Regis College, Boston, Massachusetts; and 5Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia CE credit: For CE credit, you can access the test for this article, as well as additional JNMT CE tests, online at https://www.snmmilearningcenter.org. Complete the test online no later than December 2018. Your online test will be scored immediately. You may make 3 attempts to pass the test and must answer 80% of the questions correctly to receive 1.0 CEH (Continuing Education Hour) credit. SNMMI members will have their CEH credit added to their VOICE transcript automatically; nonmembers will be able to print out a CE certificate upon successfully completing the test. The online test is free to SNMMI members; nonmembers must pay $15.00 by credit card when logging onto the website to take the test. foundation for understanding the science of electrocardiog- The nuclear medicine technologist works with electrocardio- raphy and its interpretation. graphy when performing cardiac stress testing and gated cardiac imaging and when monitoring critical patients.
    [Show full text]
  • Early Or Delayed Cardioversion in Recent-Onset Atrial Fibrillation
    The new england journal of medicine Original Article Early or Delayed Cardioversion in Recent-Onset Atrial Fibrillation N.A.H.A. Pluymaekers, E.A.M.P. Dudink, J.G.L.M. Luermans, J.G. Meeder, T. Lenderink, J. Widdershoven, J.J.J. Bucx, M. Rienstra, O. Kamp, J.M. Van Opstal, M. Alings, A. Oomen, C.J. Kirchhof, V.F. Van Dijk, H. Ramanna, A. Liem, L.R. Dekker, B.A.B. Essers, J.G.P. Tijssen, I.C. Van Gelder, and H.J.G.M. Crijns, for the RACE 7 ACWAS Investigators*​​ ABSTRACT BACKGROUND Patients with recent-onset atrial fibrillation commonly undergo immediate restora- The authors’ full names, academic degrees, tion of sinus rhythm by pharmacologic or electrical cardioversion. However, whether and affiliations are listed in the Appen- dix. Address reprint requests to Dr. Crijns immediate restoration of sinus rhythm is necessary is not known, since atrial fibril- at the Department of Cardiology, Maas- lation often terminates spontaneously. tricht University Medical Center, P. Debye- laan 25, 6229 HX Maastricht, the Nether- METHODS lands, or at hjgm . crijns@ mumc . nl. In a multicenter, randomized, open-label, noninferiority trial, we randomly assigned *A complete list of investigators in the patients with hemodynamically stable, recent-onset (<36 hours), symptomatic atrial RACE 7 ACWAS trial is provided in the fibrillation in the emergency department to be treated with a wait-and-see approach Supplementary Appendix, available at (delayed-cardioversion group) or early cardioversion. The wait-and-see approach in- NEJM.org. volved initial treatment with rate-control medication only and delayed cardioversion Drs.
    [Show full text]
  • Guide to Exercise Electrocardiogram
    Guide to the Exercise Electrocardiogram (The Treadmill Stress Test) An exercise stress test is performed to evaluate heart rate, heart rhythm, blood pressure and electrocardiographic (ECG) responses to progressive exercise. You do not need to be an athlete or to be trained to have this test for evaluation of your cardiovascular system, but you do need to be able to walk without support. The exercise ECG is used to evaluate the adequacy of blood supply to the heart during exercise that may be symptomatic or asymptomatic and to assess the extent of limitation of blood supply to the heart in people with known coronary artery disease. The test is also used to quantify effort capacity, to evaluate the effect of medications on symptoms and effort tolerance, to assess general health and prognosis, and to evaluate the heart rate and blood pressure responses to exercise before surgical procedures and before entry into programs of cardiac rehabilitation. Imaging of the heart with echocardiography or with radionuclide agents is not performed during basic exercise ECG unless prearranged by the referring physician. Pre-Registration and Testing Location Please call 2 days before the date your test is scheduled to confirm your appointment. At this time we can also answer questions you may have. Please have your referring physician complete the order form. Plan to arrive 20 minutes before the scheduled time of your test. Bring your hospital and insurance cards with you. Go directly to the test location. NewYork-Presbyterian Hospital/Weill Cornell Medical Center 212-746-4670 Exercise ECG Laboratory Starr Pavilion 520 East 70th Street, east of York Avenue New York, NY 10021 Take the Starr elevators to the 4th floor, follow the signs to room K-425.
    [Show full text]
  • Echocardiography to Supplement Stress Electrocardiography in Emergency Department Chest Pain Patients
    Original research Echocardiography to Supplement Stress Electrocardiography in Emergency Department Chest Pain Patients Mark I. Langdorf, MD, MHPE* * University of California, Irvine, Department of Emergency Medicine, Irvine, CA Eric Wei, MD† † University of Michigan, Ann Arbor, MI Ali Ghobadi, MD* Scott E. Rudkin, MD, MBA* Shahram Lotfipour, MD, MPH* Supervising Section Editor: David E. Slattery, MD Submission history: Submitted July 18, 2009; Revision Received February 21, 2010; Accepted March 24, 2010 Reprints available through open access at http://escholarship.org/uc/uciem_westjem Introduction: Chest pain (CP) patients in the Emergency Department (ED) present a diagnostic dilemma, with a low prevalence of coronary disease but grave consequences with misdiagnosis. A common diagnostic strategy involves ED cardiac monitoring while excluding myocardial necrosis, followed by stress testing. We sought to describe the use of stress echocardiography (echo) at our institution, to identify cardiac pathology compared with stress electrocardiography (ECG) alone. Methods: Retrospective cohort study of 57 urban ED Chest Pain Unit (CPU) patients from 2002- 2005 with stress testing suggesting ischemia. Our main descriptive outcome was proportion and type of discordant findings between stress ECG testing and stress echo.The secondary outcome was whether stress echo results appeared to change management. Results: Thirty-four of 57 patients [59.7%, 95% confidence interval (CI) 46.9-72.4%] had stress echo results discordant with stress ECG results. The most common discordance was an abnormal stress ECG with a normal stress echo (n=17/57, 29.8%, CI 17.9-41.7%), followed by normal stress ECG but with reversible regional wall-motion abnormality on stress echo (n = 10/57, 17.5%, CI 7.7- 27.4%).
    [Show full text]
  • Computer Processing of the Orthogonal Electrocardiogram and Vectorcardiogram
    Physiol. Res. 43: 95-98, 1993 Computer Processing of the Orthogonal Electrocardiogram and Vectorcardiogram L. BACHÂROVÀ Research Institute of Medical Informatics, Bratislava Summary The aim of this contribution was to review the possibilities of presentation of orthogonal ECG signals and to evaluate the progress in computerized electrocardiography achieved in Czechoslovakia. The information about the cardiac electric field in orthogonal electrocardiography is defined and consequently displayed as a fixed single dipole (vector). The spatial trajectory of vector end-point (spatial vectorcardiographic loop) can be presented in different ways — as orthogonal electrocardiogram, polarcardiogram, planar vectorcardiogram and decartogram, respectively. The advantages of particular methods of presentation, as well as their limitations are discussed. Computer-assisted electrocardiography was introduced in Czechoslovakia in 1974. The original AVA program has been further developed in the Research Institute of Medical Informatics (formerly Research Institute of Medical Bionics). The currently developed system CardioSys allows the utilization of all the possibilities of orthogonal ECG and vectorcardiographic presentation for clinical and epidemiological cardiology as well as for the research. Key words Orthogonal Electrocardiography - Vectorcardiography - Computer analysis The electrographic signal provides are the physiological source of electrocardiographic irreplaceable information about the status and activity potentials. The front of myocardial depolarization is in of the heart. In current clinical practice, it is mostly fact an electrical double-layer and, as such, may be registered by means of a standard 12-lead ECG system. represented by a set of regularly spaced unit vectors. However, the information obtained in this way is The vectorial sum of these unit vectors gives the characterized by a considerable redundancy.
    [Show full text]
  • June-July 2000 Part a Bulletin
    In This Issue... Disclosure of Itemized Statement Providers Must Furnish an Itemmized Statement when Requested in Writing by the Beneficiary .................................................................................................... 6 Prospective Payment System The Outpatient Code Editor Software Has Been Modified in Preparation for the Implementation of Outpatient Prospective Payment System ........................... 8 Reclassification of Certain Urban Hospitals Certain Urban Hospitals in the State of Florida May Be Permitted to Be Reclassified as Rural Hospitals................................................................................ 13 ulletin Final Medical Review Policies 33216, 53850, 70541, 82108, 83735, 87621, 93303, 94010, 95004, A0320, J0207, J2430, J2792, J3240, J7190, and J9999 .......................................... 15 B Payment of Skilled Nursing Facility Claims Involving a Terminating Medicare+Choice Plan Payment of Skilled Nursing Facility Care for Beneficiaries Involuntarily Disenrolling from M+C plans Who Have Not Met the 3-Day Stay Requirement ........................................................................................... 67 Features From the Medical Director 3 Administrative 4 lease share the Medicare A roviders PBulletin with appropriate General Information 5 members of your organization. Outpatient Prospective Payment System 7 Routing Suggestions: General Coverage 12 o Medicare Manager Hospital Services 13 o Reimbursement Director Local and Focused Medical Policies 15 o Chief Financial
    [Show full text]
  • Quantitative Electrocardiography for Prediction Of
    QUANTITATIVE ELECTROCARDIOGRAPHY FOR PREDICTION OF POSTOPERATIVE ATRIAL FIBRILLATION AFTER CARDIAC SURGERY by FLORIAN RADER, M.D. Submitted in partial fulfillment of the requirements For the degree of Master of Science Clinical Research Scholars Program CASE WESTERN RESERVE UNIVERSITY January 2010 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the thesis/dissertation of Florian Rader, M.D. candidate for the Master of Science degree*. (signed) Regis E. McFadden (chair of the committee) Eugene H. Blackstone, M.D. Ottorino Costantini, M.D. Neal Dawson, M.D. (date) 10-28-2009 *We also certify that written approval has been obtained for any proprietary material contained therein. 2 Table of Contents List of Tables 4 List of Figures 5 Acknowledgments 6 List of Abbreviations 7 Abstract 9 Text Background and Significance 10 Specific aims 12 Methods 13 Results 21 Discussion 46 Limitations 54 Conclusions 54 References 55 3 List of Tables: Table 1: Patient characteristics 24 Table 2: Clinical predictors of postoperative atrial fibrillation 37 Table 3: ECG predictors of postoperative atrial fibrillation 38 4 List of Figures: Figure 1: Relationship of anatomic and ECG changes with POAF 11 Figure 2: Patient flow chart 22 Figure 3: Occurrence of POAF by days after surgery 33 Figure 4: Occurrence of POAF by surgery type 34 Figure 5: ROC curve of final prediction model 35 Figure 6: Calibration curve of final prediction model 36 Figure 7: Adjusted Co-plots of ECG predictors 39 Figure 8: Unadjusted and adjusted co-plot of P wave amplitude 41 Figure 9: Nomogram of final prediction model 42 Figure 10: Nomogram of prediction model with pre-op variables 43 Figure 11: Calibration curve of model without ECG predictors 45 Figure 12: Left atrial sizes by P wave amplitude in aVR 48 Figure 13: Correlation matrix (P wave amplitude, aVR, and left atrial volume) 49 5 Acknowledgments: I thank Dr.
    [Show full text]
  • NC Medicaid: 1R-4, Electrocardiography
    NC Medicaid Medicaid and Health Choice Electrocardiography, Clinical Coverage Policy No.: 1R-4 Echocardiography, and Amended Date: March 15, 2019 Intravascular Ultrasound To all beneficiaries enrolled in a Prepaid Health Plan (PHP): for questions about benefits and services available on or after November 1, 2019, please contact your PHP. Table of Contents 1.0 Description of the Procedure, Product, or Service ........................................................................... 1 1.1 Electrocardiography ............................................................................................................ 1 1.1.1 Electrocardiogram .................................................................................................. 1 1.1.2 Cardiovascular Stress Test ..................................................................................... 1 1.1.3 Microvolt T-wave Alternans .................................................................................. 1 1.1.4 Holter Monitor ....................................................................................................... 1 1.1.5 Cardiac (Ambulatory) Event Monitors .................................................................. 1 1.2 Echocardiography ............................................................................................................... 2 1.2.1 Transthoracic Echocardiography (TTE) ................................................................ 2 1.2.2 Transesophageal Echocardiography (TEE) ..........................................................
    [Show full text]
  • Chapter 2 the Electrocardiogram
    THE ESC TEXTBOOK OF CARDIOVASCULAR MEDICINE 2nd edition 17 Spodick DH. Differential characteristics of the C h a p t e r 2 The Electrocardiogram electrocardiogram in early repolarization and acute pericarditis. N Engl J Med 1976; 295 : 523–6. Francisco G. Cosío, José Palacios, 18 Watanabe Y. Purkinje repolarization as a possible cause of the Agustín Pastor, and Ambrosio Núñez U wave in the electrocardiogram. Circulation 1975; 51 : 1030–7. 19 Voukydis PC. Effect of intracardiac blood on the electrocardiogram. N Engl J Med 1974; 291 : 612–16. 20 Thomas P, Dejong D. The P wave in the electrocardiogram in the diagnosis of heart disease. Br Heart J 1954; 16 : 241–54. References 21 Kaplan JD, Evans T Jr, Foster E, et al . Evaluation of electrocardiographic criteria for right atrial enlargement by 1 Grant RP. Clinical Electrocardiography: The Spatial Vector quantitative two-dimensional echocardiography. J Am Coll Approach , 1957. New York: McGraw Hill. Cardiol 1994; 23 : 747–52. 2 Sodi D, Bisteni A, Medrano G. Electrocardiografi a y 22 Reeves WC, Hallahan W, Schwitter EJ, et al . Two-dimensional Vectorcardiografi a Deductivas , Vol. I, 1964. México DF: La echocardiographic assessment of ECG criteria for right atrial Prensa Médica Mexicana. enlargement. Circulation 1981; 64 : 387–91. 3 Rosenbaum MB, Elizari MV, Lazzari JO. The Hemiblocks , 1970. 23 Sgarbossa EB, Wagner G. Electrocardiography. In Topol EJ Oldsmar, FL: Tampa Tracings. (ed) Textbook of Cardiovascular Medicine , 2007. Philadelphia, 4 Cranefi eld PF. The Conduction of the Cardiac Impulse , 1975. PA: Lippincott Williams & Wilkins, pp.977–1011. Mount Kisko. NY: Futura. 24 Hazen MS, Marwick TH, Underwood DA.
    [Show full text]